Effect of addition of anti-inflammatory medication to anti-depressant medication on C-reactive protein levels in the treatment of depression

Trial Profile

Effect of addition of anti-inflammatory medication to anti-depressant medication on C-reactive protein levels in the treatment of depression

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 10 Aug 2017

At a glance

  • Drugs Celecoxib (Primary) ; Vortioxetine
  • Indications Depression
  • Focus Therapeutic Use
  • Acronyms PREDDICT
  • Most Recent Events

    • 08 Aug 2017 Planned End Date changed from 31 Jan 2019 to 15 Apr 2019.
    • 08 Aug 2017 Planned initiation date changed from 15 Jun 2017 to 28 Aug 2017.
    • 12 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top